Identification and Construction of Combinatory Cancer Hallmark–Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer-Reference-Cited by-同舟云学术

Identification and Construction of Combinatory Cancer Hallmark–Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer

Published:2016-01-01 Issue:1 Volume:2 Page:37
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Gao Shanwu¹,Tibiche Chabane²,Zou Jinfeng²,Zaman Naif²,Trifiro Mark³,O’Connor-McCourt Maureen²,Wang Edwin⁴

Affiliation:

1. Honghe University, Yunnan Province, China2National Research Council Canada, Montreal, Quebec, Canada

2. National Research Council Canada, Montreal, Quebec, Canada

3. Department of Medicine, McGill University, Montreal, Quebec, Canada4Jewish General Hospital, Montreal, Quebec, Canada

4. National Research Council Canada, Montreal, Quebec, Canada3Department of Medicine, McGill University, Montreal, Quebec, Canada5McGill University Center for Bioinformatics, Montreal, Quebec, Canada

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and validation of a 10-gene predictive signature for response to adjuvant chemotherapy in stage II and III colon cancer;Cell Reports Medicine;2024-08

2. Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions;World Journal of Gastroenterology;2024-04-07

3. RNA expression of 6 genes from metastatic mucosal gastric cancer serves as the global prognostic marker for gastric cancer with functional validation;British Journal of Cancer;2024-03-11

4. Harnessing the power of clinical decision support systems: challenges and opportunities;Open Heart;2023-11

5. A new natural killer cell-specific gene signature predicting recurrence in colorectal cancer patients;Frontiers in Immunology;2023-01-06